Curvebeam Ai Ltd (AU:CVB) — Market Cap & Net Worth
Market Cap & Net Worth: Curvebeam Ai Ltd (CVB)
Curvebeam Ai Ltd (AU:CVB) has a market capitalization of $9.13 Million (AU$12.90 Million) as of September 20, 2026. Listed on the AU stock exchange, this Australia-based company holds position #27406 globally and #1332 in its home market, demonstrating a 35.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Curvebeam Ai Ltd's stock price AU$0.03 by its total outstanding shares 477734297 (477.73 Million). Also see how large is Curvebeam Ai Ltd's balance sheet for a full breakdown of the balance sheet.
Curvebeam Ai Ltd Market Cap History: 2023 to 2026
Curvebeam Ai Ltd's market capitalization history from 2023 to 2026. Data shows change from $140.28 Million to $9.13 Million (-56.13% CAGR). Also see how efficiently does Curvebeam Ai Ltd generate cash for how efficiently the company converts equity into cash flow.
Curvebeam Ai Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Curvebeam Ai Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CVB stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.07x
Curvebeam Ai Ltd's market cap is 2.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $140.28 Million | $8.06 Million | -$52.05 Million | 17.42x | N/A |
| 2024 | $45.63 Million | $6.53 Million | -$23.10 Million | 6.99x | N/A |
| 2025 | $25.01 Million | $12.10 Million | -$16.84 Million | 2.07x | N/A |
Competitor Companies of CVB by Market Capitalization
Companies near Curvebeam Ai Ltd in the global market cap rankings as of September 20, 2026. Review CVB intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Curvebeam Ai Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Curvebeam Ai Ltd Historical Marketcap From 2023 to 2026
Between 2023 and today, Curvebeam Ai Ltd's market cap moved from $140.28 Million to $ 9.13 Million, with a yearly change of -56.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$9.13 Million | -63.51% |
| 2025 | AU$25.01 Million | -45.19% |
| 2024 | AU$45.63 Million | -67.47% |
| 2023 | AU$140.28 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Curvebeam Ai Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.13 Million USD |
| MoneyControl | $9.13 Million USD |
| MarketWatch | $9.13 Million USD |
| marketcap.company | $9.13 Million USD |
| Reuters | $9.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Curvebeam Ai Ltd
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot … Read more